Daniela M. Ferreira

Daniela M. Ferreira publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Daniela M. Ferreira sits on this spectrum.

Daniela M. Ferreira D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Daniela M. Ferreira sits on this spectrum.

Best Publications

• Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

  M Voysey;Clemens Sac.;S A Madhi;L Y Weckx

  4904
  Citations

• Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

  M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  1285
  Citations

• Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.

  Shuo Feng;Daniel J. Phillips;Thomas White;Homesh Sayal

  1140
  Citations

• Streptococcus pneumoniae: transmission, colonization and invasion

  Jeffrey N. Weiser;Daniela M. Ferreira;James C. Paton

  1106
  Citations

• Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.

  Katherine R W Emary;Tanya Golubchik;Parvinder K Aley;Cristina V Ariani

  647
  Citations

• Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.

  Xinxue Liu;Robert H Shaw;Arabella S V Stuart;Melanie Greenland

  511
  Citations

• Pneumolysin Activates the NLRP3 Inflammasome and Promotes Proinflammatory Cytokines Independently of TLR4

  Edel A. McNeela;Áine Burke;Daniel R. Neill;Cathy Baxter

  414
  Citations

• Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

  Unknown

  357
  Citations

• Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).

  Amy Flaxman;Natalie G Marchevsky;Daniel Jenkin;Jeremy Aboagye

  235
  Citations

• Controlled Human Infection and Rechallenge with Streptococcus pneumoniae Reveals the Protective Efficacy of Carriage in Healthy Adults

  Daniela M. Ferreira;Daniel R. Neill;Mathieu Bangert;Jenna F. Gritzfeld

  206
  Citations

• Inflammation induced by influenza virus impairs human innate immune control of pneumococcus

  Simon P. Jochems;Fernando Marcon;Beatriz F. Carniel;Mark Holloway

  198
  Citations

• Experimental infection of human volunteers

  Meta Roestenberg;Marie-Astrid Hoogerwerf;Daniela M Ferreira;Benjamin Mordmüller

  175
  Citations

• Characterization of Protective Mucosal and Systemic Immune Responses Elicited by Pneumococcal Surface Protein PspA and PspC Nasal Vaccines against a Respiratory Pneumococcal Challenge in Mice

  D. M. Ferreira;M. Darrieux;D. A. Silva;L. C. C. Leite

  147
  Citations

• Human alveolar macrophages predominately express combined classical M1 and M2 surface markers in steady state.

  Unknown

  141
  Citations

• Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

  Unknown

  122
  Citations

• T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice.

  Daniel R. Neill;Vitor E. Fernandes;Laura Wisby;Andrew R. Haynes

  119
  Citations

• Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.

  M. Darrieux;E. N. Miyaji;D. M. Ferreira;L. M. Lopes

  118
  Citations

• Experimental Human Pneumococcal Carriage Augments IL-17A-dependent T-cell Defence of the Lung

  Adam K. A. Wright;Mathieu Bangert;Jenna F. Gritzfeld;Daniela M. Ferreira

  116
  Citations

• The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease

  Luke Richards;Daniela M. Ferreira;Eliane N. Miyaji;Peter W. Andrew

  114
  Citations

• Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.

  Adriana T. Moreno;Maria Leonor S. Oliveira;Daniela M. Ferreira;Paulo L. Ho

  113
  Citations